Current Surgical
Focus: Current Surgical develops micro-invasive treatment technologies focused on gastroenterology applications. The company is a pre-revenue biotechnology firm headquartered in Washington, DC.
Profile data last refreshed 48m ago · AI intelligence enriched 2w ago
Open Jobs
7
Should You Work at Current Surgical?
AI assessmentCurrent Surgical is a high-risk, early-stage opportunity best suited for engineers and technologists willing to bet on unvalidated innovation without near-term revenue visibility.
Why Work Here
- Early-stage technology company with heavy hiring in engineering (4 roles) suggests active product development and R&D momentum
- Micro-invasive treatments in gastroenterology represent a differentiated market segment with high unmet clinical need
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Current Surgical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.